Yaz Plus Tablet (2018-07-12)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 71010A | Yaz Plus Tablet | - Recalling Firm
- Bayer Inc.
- 2920 MATHESON BLVD. EAST
- MISSISSAUGA
- L4W 5R6
- Ontario
- CANADA
- Marketing Authorization Holder
- Bayer Inc.
- 2920 MATHESON BLVD. EAST
- MISSISSAUGA
- L4W 5R6
- Ontario
- CANADA
| Tablet | DIN 02387433 | DROSPIRENONE 3.00 MG |
Recalled Products
Yaz Plus Tablet
The dosage uniformity test is out of specification in the affected lots.
Wholesalers, Healthcare Establishments